CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial Sat Press Releases By John Harbison|2017-02-20T07:26:34-08:00February 2, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
